MiR-130b also inhibits tumor suppressor function in esophageal squamous cell carcinoma by repression of PTEN [47] and SASH1 [48], and in bladder cancer by targeting VGLL4 [49]. This evidence concerns the gene VGLL4 and neoplasm.